This trial will test a new cancer drug to see if it is safe and effective.
- Advanced Solid Tumors
- Stomach Cancer
- Pancreatic Cancer
- Gastroesophageal Junction Adenocarcinoma
3 Primary · 20 Secondary · Reporting Duration: 2 years
2 Treatment Groups
Monotherapy Dose Dose Finding - Part 1
1 of 2
Expansion as Monotherapy - Part 2
1 of 2
70 Total Participants · 2 Treatment Groups
Primary Treatment: TORL-2-307-ADC · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
|UCLA - JCCC Clinical Research Unit||100.0%|
What portion of applicants met pre-screening criteria?
Frequently Asked Questions
Are potential patients able to enroll in this experiment at the moment?
"Affirmatively, this clinical trial is actively recruiting patients. Initially posted on February 2nd 2022 and recently updated on the 10th of that same month, all necessary information can be found hosted on clinicaltrials.gov." - Anonymous Online Contributor
Has the Food and Drug Administration accepted TORL-2-307-ADC for use in humans?
"Due to the early stage nature of this trial, TORL-2-307-ADC received a score of 1 in terms of safety. This is because there are only limited data points illustrating its efficacy and lack thereof concerning its security." - Anonymous Online Contributor
What outcomes is this investigation attempting to realize?
"This clinical trial, evaluated over a two-year period, aims to determine the Maximum Tolerated Dose (MTD) of an unnamed medication. Secondary objectives include determining Area under the Serum Concentration-Time curve from dosing time until infinity (AUCinf), 1 Year Overall Survival rate (1YOS), and Apparent volume of distribution during terminal phase (Vz)." - Anonymous Online Contributor
How many individuals have been accepted into this clinical experiment?
"Yes, the details listed on clinicaltrials.gov demonstrate that this medical experiment is still recruiting. This research was initially posted on 2/2/2022 and has been revised as recently as 2/10/2022 - they are aiming to include 70 patients at a single location." - Anonymous Online Contributor